How aTyr Pharma ATYR pricing power shows up in earnings Q4 2025 Earnings Beat Estimates How Exelixis EXEL balances growth with profitability Trend Weakens 20260508 AIP Arteris reports narrower Q4 2025 loss than estimates stock slips 003 in daily trading Consolidated Edison Inc ED Bullish Rating Supported By Defensive Sector Positioning And Strong YTD Performance